Showing results (91-100 of 154) with videos related to
Sort By:
Pageof 16
Cancer Research|November 14, 2013
Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage populationDamya Laoui, Eva Van Overmeire, Giusy Di Conza, et al.EMBO Molecular Medicine|August 21, 2015
PHD1 regulates p53-mediated colorectal cancer chemoresistanceSofie Deschoemaeker, Giusy Di Conza, Sergio Lilla, et al.Cancer Research Communications|April 17, 2023
IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune ToleranceZoë Johnson, Chiara Tarantelli, Elisa Civanelli, et al.Plos One|July 17, 2008
PKCepsilon stimulated arginine methylation of RIP140 for its nuclear-cytoplasmic export in adipocyte differentiationPawan Gupta, Ping-Chih Ho, M D Mostaqul Huq, et al.Cell|May 11, 2015
IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell LongevityGuoliang Cui, Matthew M Staron, Simon M Gray, et al.Cell Reports|March 7, 2025
iMetAct: An integrated systematic inference of metabolic activity for dissecting tumor metabolic preference and tumor-immune microenvironmentBinxian Wang, Chao Huang, Xuan Liu, et al.Analytical Chemistry|September 19, 2019
Tape-Stripping Electrochemical Detection of MelanomaSorour Darvishi, Horst Pick, Tzu-En Lin, et al.Physiological Reviews|August 16, 2019
Immunity, Hypoxia, and Metabolism-the Ménage à Trois of Cancer: Implications for ImmunotherapyCarla Riera-Domingo, Annette Audigé, Sara Granja, et al.Haematologica|June 19, 2025
Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignanciesBinu Kandathilparambil Sasi, Chiara Tarantelli, Stephen Martindale, et al.Cell Reports|March 31, 2026
Targeting PI3Kδ suppresses pancreatic cancer by dual disruption of fibrosis and immune evasionMaciej Garczyk, Gonçalo Outeiro-Pinho, Muthita Pitaktrairat, et al.Pageof 16